Clinical Trial Update: Using FAPI PET/MRI to Evaluate Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial using FAPI PET/MRI imaging to evaluate prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FAPI PET/MRI imaging tracer (Fibroblast activation protein inhibitor tracer (FAPI))

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer Metastatic Disease, Prostate Cancers | Phase 2 | Status: RECRUITING